|
Carbamazepine
|
Increased breakthrough seizures with generic substitution
|
Sachdeo and Belendiuk (1987), Welty et al. (1992), Koch and Allen (1987), Hartley et al. (1991), Berg et al. (2008), Hartley et al. (1990)
|
|
Failure of drug therapy with generic substitution
|
Meyer et al. (1992), Welty et al. (1992), Jain (1993)
|
|
Toxicity and increased serum levels with generic substitution
|
Gilman et al. (1993), Jumao-as et al. (1989), Reunanen et al. (1992)
|
|
Adverse effects with generics
|
Neuvonen (1985), Hartley et al. (1990), Olling et al. (1999), Garnett et al. (2005)
|
|
Phenytoin
|
Increased breakthrough seizures with generic substitution
|
Yamada and Welty (Yamada and Welty 2011), Berg et al. (2008)
|
|
Toxicity and increased serum levels with generic substitution
|
Soryal and Richens (1992)
|
|
Adverse effects with generics
|
Chen et al. (1982)
|
|
Valproate
|
Increased breakthrough seizures with generic substitution
|
Berg et al. (2008)
|
|
Failure of drug therapy
|
Margolese et al. (2010), Sherr and Kelly (1998)
|
|
Toxicity and increased serum levels with generic substitution
|
Levine et al. (2000)
|
|
Adverse effects with generics
|
Margolese et al. (2010), Sherwood et al. (1998), Wassef et al. (2005), Zarate et al. (1999), Schwartz et al. (2000)
|
|
Leviteracetam
|
Increased breakthrough seizures with generic substitution
|
Armstrong et al. (2010), Fitzgerald and Jacobson (2011), Chaluvadi et al. (2011)
|
|
Adverse effects with generics
|
(Chaluvadi et al. 2011)
|
|
Topiramate
|
Increased breakthrough seizures with generic substitution
|
Duh et al. (2009b)
|
|
Adverse effects with generics
|
Pineyro-Lopez et al. (2009)
|
|
Gabapentin
|
Increased breakthrough seizures with generic substitution
|
Berg et al. (2008)
|
|
Phenobarbital
|
Failure of drug therapy
|
Bankstahl et al. (2013)
|
|
Oxcarbazepine
|
Increased breakthrough seizures with generic substitution
|
Cook et al. (2009)
|
|
Lamotrigine
|
Increased breakthrough seizures with generic substitution
|
Makus and McCormick (2007), Nielsen et al. (2008)
|
|
Toxicity and increased serum levels with generic substitution
|
Srichaiya et al. (2008), Sabroe and Sabers (2008), Nielsen et al. (2008)
|
|
Adverse effects with generics
|
Andermann et al. (2007), Makus and McCormick (2007)
|
|
Primidone
|
Increased breakthrough seizures with generic substitution
|
Wyllie et al. (1987)
|
|
Zonisamide
|
Increased breakthrough seizures with generic substitution
|
Berg et al. (2008)
|
